Abstract: Various embodiments are described herein for a system and a method for assessing a risk of ventricular arrhythmias for a patient. For example, the method may comprise receiving ECG data obtained from the patient; analyzing the ECG data to detect abnormal QRS peaks; determining the risk of ventricular arrhythmias for the patient based on the detected abnormal QRS peaks; and providing an indication of the risk of ventricular arrhythmias for the patient. The system may be configured to perform this method.

Abstract: Various embodiments are described herein for a system and a method for assessing a risk of ventricular arrhythmias for a patient. For example, the method may comprise receiving ECG data obtained from the patient; analyzing the ECG data to detect abnormal QRS peaks; determining the risk of ventricular arrhythmias for the patient based on the detected abnormal QRS peaks; and providing an indication of the risk of ventricular arrhythmias for the patient. The system may be configured to perform this method.

Abstract: System, method and computer program product of assessing the likelihood of response to cardiac resynchronization therapy (CRT) for a patient. ECG data is obtained from the patient and is analyzed to detect abnormal QRS peaks. A likelihood of the patient responding to CRT is determined based on the number of abnormal QRS peaks detected. An indication of whether the patient is a candidate for CRT can be provided based on the determined likelihood of CRT response. This indication can be used to guide treatment for the patient.

Abstract: Various embodiments are described herein for detecting a rotor at a location of a heart that experiences cardiac fibrillation. This generally involves obtaining a plurality of bipolar EGMs for a recording duration using a circular bipolar electrode array positioned at the location of the heart; detecting a dominant periodicity Cycle Length (CL) and identifying periodic activations for each bipolar EGM associated with the dominant periodicity CL; tracking the identified periodic activations across each bipolar EGM to define rotational activations and determining when a path taken by the tracked rotational activations corresponds to a rotational activation pattern of a rotor; and detecting the rotor when a number and completeness of the tracked rotational activations meet predefined rotor criteria.

Abstract: Various embodiments are described herein for a system, method, and device for identifying focal source locations of electrophysiological activity in an organ. The system, method and device may also be used to guide catheter ablation of the organ. An electrogram signal can be obtained from a location in the organ, and it can be determined if the electrogram is periodic and, if so, the corresponding periodicity cycle length. A plurality of peaks associated with the cycle length can be identified. The location can be identified as a focal source location when the periodicity cycle length and the plurality of peaks have focal source characteristics. Methods are also described for identifying a direction of wave propagation and identifying multiple periodicities within an electrogram signal.

Abstract: Various embodiments are described herein for a system and a method for assessing a risk of ventricular arrhythmias for a patient. For example, the method may comprise receiving ECG data obtained from the patient; analyzing the ECG data to detect abnormal QRS peaks; determining the risk of ventricular arrhythmias for the patient based on the detected abnormal QRS peaks; and providing an indication of the risk of ventricular arrhythmias for the patient. The system may be configured to perform this method.

Abstract: Various embodiments are described herein for detecting a rotor at a location of a heart that experiences cardiac fibrillation. This generally involves obtaining a plurality of bipolar EGMs for a recording duration using a circular bipolar electrode array positioned at the location of the heart; detecting a dominant periodicity Cycle Length (CL) and identifying periodic activations for each bipolar EGM associated with the dominant periodicity CL; tracking the identified periodic activations across each bipolar EGM to define rotational activations and determining when a path taken by the tracked rotational activations corresponds to a rotational activation pattern of a rotor; and detecting the rotor when a number and completeness of the tracked rotational activations meet predefined rotor criteria.

Abstract: Various embodiments are described herein for a system, method, and device for identifying focal source locations of electrophysiological activity in an organ. The system, method and device may also be used to guide catheter ablation of the organ. An electro-gram signal can be obtained from a location in the organ, and it can be determined if the electrogram is periodic and, if so, the corresponding periodicity cycle length. A plurality of peaks associated with the cycle length can be identified. The location can be identified as a focal source location when the periodicity cycle length and the plurality of peaks have focal source characteristics. Methods are also described for identifying a direction of wave propagation and identifying multiple periodicities within an electrogram signal.

Abstract: A process for preparing an extract of Momordica charantia, including: a) preparing crude juice; b) filtering to obtain filtered juice; c) modifying pH; d) allowing the pH modified juice to stabilize; e) neutralizing the stabilized juice; f) allowing the neutralized juice to stand for 20-30 minutes; g) rechecking the pH level; and h) drying the juice to obtain the extract. The process said above is simple, cost effective, which does not employ any harmful organic solvents and which enhances the potency of the constituents. A simple and potent formulation showing anti-diabetic activity comprising active constituents of Momordica charantia is also provided.

Abstract: A process for preparing an extract of Momordica charantia, including: a) preparing crude juice; b) filtering to obtain filtered juice; c) modifying pH; d) allowing the pH modified juice to stabilize; e) neutralizing the stabilized juice; f) allowing the neutralized juice to stand for 20-30 minutes; g) rechecking the pH level; and h) drying the juice to obtain the extract. The process said above is simple, cost effective, which does not employ any harmful organic solvents and which enhances the potency of the constituents. A simple and potent formulation showing anti-diabetic activity comprising active constituents of Momordica charantia is also provided.

Abstract: An oral herbal composition comprising a therapeutically effective amount of an extract derived from the berries of a plant, Piper cubeba, wherein the composition is provided for use in the treatment of oral candidiasis (oral thrush). The oral herbal composition can be formulated in the form of a candy, a chewable tablet and an oral gel. The herbal composition exhibits antifungal activity against azole resistant strains of Candida albicans. The herbal composition is safe to administer and has improved patient compliance.

Abstract: An oral herbal composition comprising a therapeutically effective amount of an extract derived from the berries of a plant, Piper cubeba, wherein the composition is provided for use in the treatment of oral candidiasis (oral thrush). The oral herbal composition can be formulated in the form of a candy, a chewable tablet and an oral gel. The herbal composition exhibits antifungal activity against azole resistant strains of Candida albicans. The herbal composition is safe to administer and has improved patient compliance.

Abstract: Compositions containing extract of hedychium spicatum are useful for treating Tinea infections by topical application. Extracts from rhizomes of hedychium spicatum are particularly useful.

Abstract: Compositions containing extract of hedychium spicatum are useful for treating Tinea infections by topical application. Extracts from rhizomes of hedychium spicatum are particularly useful.